摘要
目的:为临床制订个体化给药方案提供参考。方法:采用化学发光免疫分析法对我院2013年监测的436例/次地高辛血药浓度监测结果进行统计和分析。结果:患者以男性为主,占65.36%;65岁以上患者占84.17%;血药浓度在0.5-2.0 ng/ml范围的有281例,占64.45%;血药浓度〉2.0或〈0.5 ng/ml的分别占22.25%和13.30%;女性平均血药浓度高于男性,其中血药浓度〉2.0 ng/ml的女性患者占30.46%,亦高于男性患者(17.89%)。结论:地高辛血药浓度受患者年龄、性别等因素影响。血药浓度监测结果应与患者的生理、病理情况及临床表现结合,以制订个体化给药方案。
OBJECTIVE:To analyze the results of digoxin blood concentration monitoring and provide references for clinical rational drug use. METHODS:Chemiluminescence immunoassay technique was conducted to count and analyze 436 cases/times of digoxin blood concentrations monitoring results of our hospital in 2013. RESULTS:Most patients were male,accounting for65.36%,and the patients over 65 years old accounted for 84.17%. Concentration in the range of 0.5-2.0 ng/ml accounted for64.45%,22.25% were 2.0 ng/ml and 13.30% were 0.5 ng/ml. The average drug concentration of female was higher than that of male,which female patients 2.0 ng/ml accounted for 30.46%,and higher than male patients(17.89%). CONCLUSIONS:Digoxin blood concentration is influenced by age,gender and other factors. The individualized regimen should be developed on the basis of blood concentration monitoring,physiology,pathology and clinical manifestations.
出处
《中国药房》
CAS
北大核心
2015年第11期1499-1501,共3页
China Pharmacy
关键词
地高辛
性别
血药浓度监测
年龄
Digoxin Gender Blood concentration monitoring Age